Global Tuberculosis Therapeutics Market Size, Status and Forecast 2025

March 2018 | 90 pages | ID: G08E2763918QEN
QYResearch

Abstracts

This report studies the global Tuberculosis Therapeutics market, analyzes and researches the Tuberculosis Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Aventis Pharmaceuticals
• Sanofi -Aventis
• Versapharma Incorporated
• Sigma Pharmaceutical Pty
• Novartis AG
• Hoffmann-La Roche
• Bayer Health Care

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Isoniazid
• Rifampin
• Pyrazinamide
• Hydrazine Derivatives
• Miscellaneous Anti-Tubercular Drugs
• Ethambutol

Market segment by Application, Tuberculosis Therapeutics can be split into

• Ambulatory Surgical Centers
• Hospital Pharmacies
• Individual Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Tuberculosis Therapeutics Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF TUBERCULOSIS THERAPEUTICS

1.1 Tuberculosis Therapeutics Market Overview
  1.1.1 Tuberculosis Therapeutics Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Tuberculosis Therapeutics Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Tuberculosis Therapeutics Market by Type
  1.3.1 Isoniazid
  1.3.2 Rifampin
  1.3.3 Pyrazinamide
  1.3.4 Hydrazine Derivatives
  1.3.5 Miscellaneous Anti-Tubercular Drugs
  1.3.6 Ethambutol
1.4 Tuberculosis Therapeutics Market by End Users/Application
  1.4.1 Ambulatory Surgical Centers
  1.4.2 Hospital Pharmacies
  1.4.3 Individual Pharmacies

2 GLOBAL TUBERCULOSIS THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS

2.1 Tuberculosis Therapeutics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Aventis Pharmaceuticals
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Tuberculosis Therapeutics Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Sanofi -Aventis
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Tuberculosis Therapeutics Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Versapharma Incorporated
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Tuberculosis Therapeutics Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Sigma Pharmaceutical Pty
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Tuberculosis Therapeutics Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Novartis AG
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Tuberculosis Therapeutics Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Hoffmann-La Roche
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Tuberculosis Therapeutics Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Bayer Health Care
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Tuberculosis Therapeutics Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments

4 GLOBAL TUBERCULOSIS THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Tuberculosis Therapeutics Market Size by Type (2013-2018)
4.2 Global Tuberculosis Therapeutics Market Size by Application (2013-2018)
4.3 Potential Application of Tuberculosis Therapeutics in Future
4.4 Top Consumer/End Users of Tuberculosis Therapeutics

5 UNITED STATES TUBERCULOSIS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Tuberculosis Therapeutics Market Size (2013-2018)
5.2 United States Tuberculosis Therapeutics Market Size and Market Share by Players (2013-2018)
5.3 United States Tuberculosis Therapeutics Market Size by Application (2013-2018)

6 EU TUBERCULOSIS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Tuberculosis Therapeutics Market Size (2013-2018)
6.2 EU Tuberculosis Therapeutics Market Size and Market Share by Players (2013-2018)
6.3 EU Tuberculosis Therapeutics Market Size by Application (2013-2018)

7 JAPAN TUBERCULOSIS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Tuberculosis Therapeutics Market Size (2013-2018)
7.2 Japan Tuberculosis Therapeutics Market Size and Market Share by Players (2013-2018)
7.3 Japan Tuberculosis Therapeutics Market Size by Application (2013-2018)

8 CHINA TUBERCULOSIS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Tuberculosis Therapeutics Market Size (2013-2018)
8.2 China Tuberculosis Therapeutics Market Size and Market Share by Players (2013-2018)
8.3 China Tuberculosis Therapeutics Market Size by Application (2013-2018)

9 INDIA TUBERCULOSIS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Tuberculosis Therapeutics Market Size (2013-2018)
9.2 India Tuberculosis Therapeutics Market Size and Market Share by Players (2013-2018)
9.3 India Tuberculosis Therapeutics Market Size by Application (2013-2018)

10 SOUTHEAST ASIA TUBERCULOSIS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Tuberculosis Therapeutics Market Size (2013-2018)
10.2 Southeast Asia Tuberculosis Therapeutics Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Tuberculosis Therapeutics Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Tuberculosis Therapeutics Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Tuberculosis Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.2 EU Tuberculosis Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Tuberculosis Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.4 China Tuberculosis Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.5 India Tuberculosis Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Tuberculosis Therapeutics Revenue and Growth Rate (2018-2025)
11.2 Global Tuberculosis Therapeutics Market Size (Value) by Type (2018-2025)
11.3 Global Tuberculosis Therapeutics Market Size by Application (2018-2025)

12 TUBERCULOSIS THERAPEUTICS MARKET DYNAMICS

12.1 Tuberculosis Therapeutics Market Opportunities
12.2 Tuberculosis Therapeutics Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Tuberculosis Therapeutics Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Tuberculosis Therapeutics Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Tuberculosis Therapeutics Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Tuberculosis Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Tuberculosis Therapeutics Market Share by Regions (2013-2018)
Figure United States Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Tuberculosis Therapeutics Revenue Market Share by Type in 2017
Figure Isoniazid Market Size (Million USD) and Growth Rate (2013-2018)
Figure Rifampin Market Size (Million USD) and Growth Rate (2013-2018)
Figure Pyrazinamide Market Size (Million USD) and Growth Rate (2013-2018)
Figure Hydrazine Derivatives Market Size (Million USD) and Growth Rate (2013-2018)
Figure Miscellaneous Anti-Tubercular Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Ethambutol Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Tuberculosis Therapeutics Market Share by Application in 2017
Figure Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate in Ambulatory Surgical Centers (2013-2018)
Figure Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018)
Figure Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate in Individual Pharmacies (2013-2018)
Table Tuberculosis Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Tuberculosis Therapeutics Market Size Share by Players in 2013
Figure Tuberculosis Therapeutics Market Size Share by Players in 2017
Table Aventis Pharmaceuticals Basic Information List
Table Tuberculosis Therapeutics Business Revenue (Million USD) of Aventis Pharmaceuticals (2013-2018)
Figure Aventis Pharmaceuticals Tuberculosis Therapeutics Business Revenue Market Share (2013-2018)
Table Sanofi -Aventis Basic Information List
Table Tuberculosis Therapeutics Business Revenue (Million USD) of Sanofi -Aventis (2013-2018)
Figure Sanofi -Aventis Tuberculosis Therapeutics Business Revenue Market Share (2013-2018)
Table Versapharma Incorporated Basic Information List
Table Tuberculosis Therapeutics Business Revenue (Million USD) of Versapharma Incorporated (2013-2018)
Figure Versapharma Incorporated Tuberculosis Therapeutics Business Revenue Market Share (2013-2018)
Table Sigma Pharmaceutical Pty Basic Information List
Table Tuberculosis Therapeutics Business Revenue (Million USD) of Sigma Pharmaceutical Pty (2013-2018)
Figure Sigma Pharmaceutical Pty Tuberculosis Therapeutics Business Revenue Market Share (2013-2018)
Table Novartis AG Basic Information List
Table Tuberculosis Therapeutics Business Revenue (Million USD) of Novartis AG (2013-2018)
Figure Novartis AG Tuberculosis Therapeutics Business Revenue Market Share (2013-2018)
Table Hoffmann-La Roche Basic Information List
Table Tuberculosis Therapeutics Business Revenue (Million USD) of Hoffmann-La Roche (2013-2018)
Figure Hoffmann-La Roche Tuberculosis Therapeutics Business Revenue Market Share (2013-2018)
Table Bayer Health Care Basic Information List
Table Tuberculosis Therapeutics Business Revenue (Million USD) of Bayer Health Care (2013-2018)
Figure Bayer Health Care Tuberculosis Therapeutics Business Revenue Market Share (2013-2018)
Table Global Tuberculosis Therapeutics Market Size (Million USD) by Product (2013-2018)
Figure Global Tuberculosis Therapeutics Revenue Market Share (%) by Product (2013-2018)
Figure Global Tuberculosis Therapeutics Market Share by Product in 2017
Table Global Tuberculosis Therapeutics Market Size by Application (2013-2018)
Figure Global Tuberculosis Therapeutics Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Tuberculosis Therapeutics
Figure United States Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Tuberculosis Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure United States Tuberculosis Therapeutics Market Size Share by Players in 2013
Figure United States Tuberculosis Therapeutics Market Size Share by Players in 2017
Table United States Tuberculosis Therapeutics Market Size by Application (2013-2018)
Figure United States Tuberculosis Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure United States Tuberculosis Therapeutics Market Size Share by Application in 2017
Figure EU Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Tuberculosis Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure EU Tuberculosis Therapeutics Market Size Share by Players in 2013
Figure EU Tuberculosis Therapeutics Market Size Share by Players in 2017
Table EU Tuberculosis Therapeutics Market Size by Application (2013-2018)
Figure EU Tuberculosis Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure EU Tuberculosis Therapeutics Market Size Share by Application in 2017
Figure Japan Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Tuberculosis Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Japan Tuberculosis Therapeutics Market Size Share by Players in 2013
Figure Japan Tuberculosis Therapeutics Market Size Share by Players in 2017
Table Japan Tuberculosis Therapeutics Market Size by Application (2013-2018)
Figure Japan Tuberculosis Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Japan Tuberculosis Therapeutics Market Size Share by Application in 2017
Figure China Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table China Tuberculosis Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure China Tuberculosis Therapeutics Market Size Share by Players in 2013
Figure China Tuberculosis Therapeutics Market Size Share by Players in 2017
Table China Tuberculosis Therapeutics Market Size by Application (2013-2018)
Figure China Tuberculosis Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure China Tuberculosis Therapeutics Market Size Share by Application in 2017
Figure India Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table India Tuberculosis Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure India Tuberculosis Therapeutics Market Size Share by Players in 2013
Figure India Tuberculosis Therapeutics Market Size Share by Players in 2017
Table India Tuberculosis Therapeutics Market Size by Application (2013-2018)
Figure India Tuberculosis Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure India Tuberculosis Therapeutics Market Size Share by Application in 2017
Figure Southeast Asia Tuberculosis Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Tuberculosis Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Tuberculosis Therapeutics Market Size Share by Players in 2013
Figure Southeast Asia Tuberculosis Therapeutics Market Size Share by Players in 2017
Table Southeast Asia Tuberculosis Therapeutics Market Size by Application (2013-2018)
Figure Southeast Asia Tuberculosis Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Tuberculosis Therapeutics Market Size Share by Application in 2017
Figure Global Tuberculosis Therapeutics Market Size and Growth Rate (2018-2025)
Table Global Tuberculosis Therapeutics Market Size (Million USD) by Regions (2018-2025)
Figure Global Tuberculosis Therapeutics Market Size Share (2018-2025)
Figure Global Tuberculosis Therapeutics Market Size Share by Regions in 2025
Figure United States Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Tuberculosis Therapeutics Market Size (Million USD) by Type (2018-2025)
Figure Global Tuberculosis Therapeutics Market Size Share by Type in 2018
Figure Global Tuberculosis Therapeutics Market Size Share by Type in 2025
Table Global Tuberculosis Therapeutics Market Size (Million USD) by Application (2018-2025)
Figure Global Tuberculosis Therapeutics Market Size (Million USD) by Application in 2018
Figure Global Tuberculosis Therapeutics Market Size (Million USD) by Application in 2025